Base Year
Historical Year
Forecast Year
The global swine healthcare market size is further expected to grow in the forecast period of 2024-2032 at a CAGR of 7.90%.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Diagnostic tests are crucial for swine diseases for early detection and subsequent start of the treatment procedures. The surge in the cases of swine fever and swine influenza, and associated deaths has led to the enhancement of swine disease diagnostic facilities in hospitals and clinics. Over the forecast period, the technological advancements in diagnostic procedures in laboratories to increase the understanding of swine disease investigation algorithm are likely to bolster the segment’s growth.
Moreover, the anticipated increase in the incorporation of diagnostic imaging in veterinary hospitals is likely to generate demand for accessories and diagnostic equipment in the coming years, supporting the overall swine healthcare market. The increasing research and development activities in laboratory diagnostics, particularly for African swine fever to facilitate quick and efficient diagnostics to enhance the recovery process from the potential fatality are further propelling the segment’s growth.
The market in the North America region is being driven by the policies of the governments which are favouring the research and development activities in therapeutic and pharmaceutical laboratories committed towards the development of swine disease treatment medications. The United States is one of the highest spenders on healthcare which is a major driving factor of the market.
In addition to this, the United States has the largest pork eating population. This factor is further escalating concerns pertaining to swine healthcare. Furthermore, the thriving commercial pork production in the region owing to the increasing exports and rising domestic demand is likely to provide impetus to the market in the coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Swine healthcare is defined as an umbrella term which includes healthcare products, diagnostic kits, and treatment procedures, aimed towards bolstering comfort during various types of swine diseases. Swine disease can happen to both humans and pigs and require efficient treatment in order to prevent fatalities. The swine healthcare market has been divided based on product, diseases, and distribution channels, among others.
Based on product, the market can be segmented into:
By disease, the swine healthcare market has been divided into:
On the basis of route of administration, the market has been categorised into:
The major distribution channels based on which the market has been segmented are as follows:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global swine healthcare market is being driven by the increasing prevalence of respiratory diseases and swine dysentery. This is propelling the demand for swine healthcare products from hospitals and clinics in order to bolster the diagnostic and treatment process for timely recovery. Meanwhile, the robust promotion of government initiatives and schemes encouraging the development of vaccines to prevent swine flu and swine fever is further propelling the market growth.
The anticipated increase in the research and development activities aimed towards the bringing innovative oral treatments to the market, owing to the increasing inclination towards minimally invasive treatment procedures, is likely to add to the market growth. The rising pork and beacon eating population is anticipated to propel the demand for healthy swine livestock in the forecast period which is likely to pose great impact on the swine healthcare market in the future.
The report gives a detailed analysis of the following key players in the global market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Diseases |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is estimated to grow at a CAGR of 7.90% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032.
The growing research and development activities aimed towards developing therapeutics for swine disease treatment are likely to be the key trends in the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major market drivers include the increasing prevalence of swine dysentery and swine fever, increasing demand for pork in western countries, and rapid development of oral treatment for swine diseases.
Diagnostic tests and therapeutics are the different segments based on product.
Exudative dermatitis, coccidiosis, respiratory diseases, swine dysentery, and porcine parvovirus, among others is the segmentation of market based on disease.
Injectable and oral are the routes of administration based on which the market has been bifurcated.
Veterinary hospitals, retail pharmacy, and online are the different channels of distribution considered in the market report.
The major players in the industry are Boehringer Ingelheim International GmbH, Phibro Animal Health Corporation, Merck & Co., Inc., Ceva Animal Health, LLC, IDEXX Laboratories, Inc, and Virbac Corporation, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share